Agomelatine Tablets Market
Agomelatine Tablets Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Agomelatine Tablets Market Size and Growth
The Agomelatine Tablets market is expanding, driven by increased demand for innovative antidepressant therapies. The market size is projected to reach approximately $300 million by 2026, with significant growth in Europe and North America. Key factors include rising mental health awareness and advancements in pharmacological research, shaping market dynamics and competitiveness. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Servier
◍ Rovi Pharma
◍ Novartis
◍ Nectid
◍
The Agomelatine Tablets Market features companies like Servier, Rovi Pharma, Novartis, Nectid, and Jiangsu Haosen, which enhance market growth through diverse formulations and regional expansions. Servier leads with innovative marketing and partnerships. Revenue figures include Servier’s €4.5 billion (2022) and Novartis at $48.5 billion (2022).
Jiangsu Haosen Pharmaceutical Group
Market Segmentation
By Application
Hospital
Clinic
By
Product
◍ Serotonin 2C Agonist
Melatonin Receptor 2 Agonist
Melatonin Receptor 1 Agonist
Serotonin Receptor Agonist
Serotonin 2C Receptor Antagonist
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
